Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities

BACKGROUND: To explore the impact of patient-characteristics and relevant comorbidities on treatment continuation rates, effectiveness, and satisfaction in patients with erectile dysfunction (ED) who started or switched to tadalafil 5 mg once daily (TAD-OaD) at baseline. METHODS: In the EDATE observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatzichristou, Dimitrios, d’Anzeo, Gianluca, Porst, Hartmut, Buvat, Jacques, Henneges, Carsten, Rossi, Andrea, Hamidi, Karim, Büttner, Hartwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643510/
https://www.ncbi.nlm.nih.gov/pubmed/26563171
http://dx.doi.org/10.1186/s12894-015-0107-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643510/
https://www.ncbi.nlm.nih.gov/pubmed/26563171
http://dx.doi.org/10.1186/s12894-015-0107-5

Ejemplares similares